United States News Todas as matérias

NeuroOne (NASDAQ:NMTC) reported unaudited preliminary financial figures for the fiscal fourth quarter and full-year period ending September 30, 2026.

Abbott (NYSE:ABT) received regulatory clearance from the U.S. Food and Drug Administration for major software capabilities connected to its implanted heart-monitoring platform.

TELUS (NYSE:TU) finalized a key technical milestone alongside AST SpaceMobile by testing direct satellite connectivity with standard mobile devices.

INNOVATE (NYSE:VATE) finalized the divestiture of its majority interest in DBM Global to IES Holdings (NASDAQ:IESC).

Skyworks (NASDAQ:SWKS) finalized its strategic combination with Qorvo, uniting two major players in radio frequency, analog, and power semiconductor solutions.

Clean Harbors (NYSE:CLH) completed the acquisitions of EnviroServe and ES&H for a combined purchase price of $775 million in cash and senior notes.

DoorDash (NASDAQ:DASH) brand Deliveroo partnered with Coco Robotics to launch autonomous robot deliveries across the UK beginning in Canary Wharf, London, in October.

Establishment Labs Holdings (NASDAQ:ESTA) secured U.S. Food and Drug Administration approval for an expanded range of Motiva SmoothSilk Round and Ergonomix breast implants.

GE HealthCare (NASDAQ:GEHC) executed a definitive agreement to acquire SOFIE Biosciences from Trilantic North America for a cash purchase price of $945 million.

Alector (NASDAQ:ALEC) executed an exclusive global licensing agreement with Genentech for AL050, an investigational enzyme replacement therapy targeting Parkinson’s disease.

Harrow (NASDAQ:HROW) closed the acquisition of TYRVAYA from Viatris to expand its commercial ophthalmic portfolio with an approved dry eye treatment.

Rezolute (NASDAQ:RZLT) announced that the U.S. Food and Drug Administration recommended a pre-BLA meeting prior to any potential biologics license application for ersodetug.

Stoke Therapeutics (NASDAQ:STOK) announced the successful completion of a meeting with the U.S. Food and Drug Administration regarding its investigational zorevunersen treatment.

C.H. Robinson (NASDAQ:CHRW) agreed to acquire RXO (NYSE:RXO) in a $5.8 billion stock-and-cash transaction.

ANI Pharmaceuticals (NASDAQ:ANIP) announced results from the U.S. open-label, single-arm Phase 4 SYNCHRONICITY study evaluating fluocinolone acetonide intravitreal implant 0.18 mg in patients with chronic non-infectious inflammation affecting the back of the eye.

Summit Therapeutics (NASDAQ:SMMT) completed a $2 billion strategic equity investment from AstraZeneca (NASDAQ:AZN) to advance its clinical oncology pipeline.

The GEO Group (NYSE:GEO) completed the $950 million sale of three California processing centers to the Department of Homeland Security.

ECARX (NASDAQ:ECX) acquired the Flyme software business portfolio for RMB 1.8 billion to bring operating systems in-house.

Advanced Drainage Systems (NYSE:WMS) executed a definitive agreement to acquire StormTrap Investments for approximately $530 million.

SFL Corporation (NYSE:SFL) agreed to build 2 Very Large Ammonia Carriers paired with long-term time charters.

Maximus (NYSE:MMS) declared a quarterly cash dividend of $0.33 per share for the fourth quarter.

Vaxcyte (NASDAQ:PCVX) reported that VAX-31 met all prespecified primary endpoints in its OPUS-1 Phase 3 trial.

Cenovus Energy (NYSE:CVE) agreed to acquire Athabasca Oil in a cash-and-stock transaction with an implied enterprise value of C$5.7 billion.

Oshkosh Corporation (NYSE:OSK) secured a second Direct Commercial Sales order to supply heavy tactical vehicles to Morocco.